Tag: Africa

  • Conagen develops debondable adhesive for textiles and soft materials from natural bioingredients

    Sustainable hot melt adhesives pave the way for textile reworking and recycling.

    Bedford, Mass., July 11, 2023 (GLOBE NEWSWIRE) — When more than 92 million tons of textile waste are landfilled annually, new solutions are needed to enable fabric reworking in manufacturing and recycling on a mass scale. Conagen, the biotechnology innovator, announced the development of a groundbreaking debondable textile adhesive made from high-performance materials sourced from sustainable and natural biomolecules.

    Conagen’s debondable adhesive offers a major application in the realm of reworkability during clothing production. Traditionally, when mistakes occur during manufacturing, it can lead to material wastage and additional production costs.

    The reworkability aspect of Conagen’s adhesive presents a game-changing solution for the clothing industry. It allows for quick and efficient correction of errors without the need to discard and waste valuable materials. Adjustments can be made by simply debonding the adhesive and the fabric components can be seamlessly reworked, resulting in improved production efficiency, reduced material waste, and significant cost savings for manufacturers.

    Moreover, debonding textile fabric plays a vital role in textile recycling by enabling efficient material separation, preserving material quality, expanding recycling opportunities, and advancing the goals of a circular economy.

    Traditional adhesives used in garment manufacturing often create a permanent bond, making it challenging to separate fabric components during recycling. Conagen’s debondable adhesive not only drives sustainability through fabric recycling but also offers a practical and economical solution for optimizing production processes in the clothing industry. The ability to debond and rework materials bring newfound flexibility and efficiency, benefiting manufacturers and the environment.
    Top of Form
    Bottom of Form

    “Conagen’s pioneering adhesive has unlocked new possibilities and opportunities. This groundbreaking development enables efficient material separation during reworking and recycling processes and preserves the integrity of textile fibers, ensuring their quality for future utilization,” stated Sara Johnson, senior materials scientist. “With the introduction of Conagen’s adhesive, we are taking a significant stride towards achieving a more sustainable and environmentally responsible textile industry.”

    Having previously created debondable adhesives for other sectors, such as appliances, smartphones, cars, and more, Conagen identified the significant benefits such an adhesive could bring to the textile and clothing industry and tailored a new product specifically to its needs.

    Adhesives and tapes are commonly used today in garment manufacturing, either alone or in combination with stitching. This is particularly evident in the manufacturing of women’s underwear, where up to six layers of material are often glued together to achieve the desired fit and comfort. It is essential to bring attention to these modern manufacturing methods as they reflect the evolution of textile production.

    Conagen’s new adhesive offering provides strength comparable to existing fabric adhesives but with the added feature of controlled debondability at end-of-life. Inspired by self-healing materials, Conagen utilizes sustainable and natural ingredients to create high-strength debondable hot melt adhesives. Unlike traditional offerings, this new adhesive is designed with reversibility, exhibiting the strength of conventionally cured adhesives, with the added benefit of transitioning to a flowable material after heating.

    Conagen’s high-strength debondable textile adhesive can be used for garments, but also extends to accessories and other soft goods applications. Furthermore, the technology is compatible with both natural and synthetic fibers and materials.

    To develop sustainable debondable textile adhesives, Conagen leverages its precision fermentation technology, independent of plant source materials, to create more efficient and sustainable bio-based ingredients compared to chemically-synthesized versions.

    Conagen’s fermentation technology is forging a path towards a more sustainable future, where the utilization of sustainable biocompounds and biomaterials takes center stage in propelling high-performance solutions that prioritize environmental consciousness,” said J. McNamara, vice president of chemical applications.

    The seam tapes market stood at $128 million in 2020. It was projected to exhibit a CAGR of 6.9% between 2020 and 2025, making Conagen’s adhesive formulation lucrative for a supplier to distribute to clothing manufacturers.

    Debondable adhesives have the potential to significantly impact the market by offering a more sustainable and efficient solution for fabric bonding. The ability to easily debond materials could lead to increased adoption of adhesive-based manufacturing techniques and open up new opportunities for textile reworking and recycling, thereby potentially expanding the market for debondable adhesive products.

    Conagen’s hallmark in biotech specialty and industrial space lies in discovering applications from the platform of natural biocompounds and biomaterials, ushering in a new era of high-performing and sustainable materials.

    “By harnessing the power of fermentation, Conagen is leading the charge in promoting greener alternatives and revolutionizing industries with its commitment to sustainability and innovation,” said McNamara.

    Conagen’s commitment to green chemicals and sustainability has been greatly reinforced by its strategic partnership with Sumitomo Chemical. The collaboration represents a major step forward in their shared vision of developing biosolutions for a more sustainable future.

    About Conagen

    Conagen is a product-focused, synthetic biology R&D company with large-scale manufacturing capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

    Attachments

    Ana Capretz, Head of Public Relations and Communications
    Conagen
    +1-781-271-1588
    [email protected]
    

    GlobeNewswire Distribution ID 8872187

  • Bridge International Academies highlights the importance of educating girls this World Population Day

    Bridge Nigeria pupil in class

    _SAM8621 (2)

    Bridge Nigeria pupil in class

    NAIROBI, Kenya, July 11, 2023 (GLOBE NEWSWIRE) — Bridge International Academies is drawing attention to the urgency of educating African girls this World Population Day (11th July) – the first time Sub-Saharan Africa will have the largest population of children on the planet.

    The schools network, which includes Bridge Kenya, Bridge Nigeria and Bridge Uganda, supports children and parents in underserved communities by providing an excellent education.

    This World Population Day focuses on the theme of ‘gender equality and women’s empowerment as a key factor in reducing poverty.’

    Reuben Wambugu, Bridge Group Managing Director, said, “By 2050 Africa and Asia will be home to 85% of the world’s young people, with the larger proportion in Africa. Currently, only 10% of children in sub-Saharan Africa are able to read a simple sentence by the age of 10. If these young people aren’t provided with an adequate education, there will be a global shortage of scientists, doctors and engineers. This could lead to a range of possible global catastrophes. Educating women and girls has proved particularly effective in reducing poverty on a local level in the short term. And with the children of educated women shown to be healthier and better educated, this leads to faster and sustained poverty reduction through generations.

    He continued, “While Bridge has seen fantastic improvements in learning outcomes for all those attending our schools, it is particularly heartening that Bridge’s methodology has succeeded in achieving gender parity in the classroom. A new study by Nobel Prize winning economist Professor Michael Kremer in our Bridge Kenya schools confirms this, finding girls make the same leaps in learning as boys.”

    Speaking on the success of Bridge’s methods, Bridge Nigeria Managing Director Foyinsola Akinjayeju said, “Bridge’s model focuses on arming teachers with scientifically proven techniques to elevate the learning of girls. Through approaches, such as gender sensitive instruction in lesson and textbook materials, expecting equal participation through ‘cold calling’ of boys and girls in the classroom and the use of female school leaders as role models, girls are empowered to succeed. By pushing this approach and the importance of women’s empowerment, Bridge Nigeria alone has provided a life-changing education to tens of thousands of girls in underserved communities, helping them complete primary school, do well in secondary school and open up opportunities offering prosperity and success.”

    To learn more about the Bridge methodology – visit their website here.

    You can reach out to Bridge International Academies at info@bridgeinternationalacademies.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/db9775c7-c35b-483b-b919-d894909f989d

    GlobeNewswire Distribution ID 1000829295

  • Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Power Processors

    The Apollo4 Lite and Apollo4 Blue Lite System-on-Chips (SoCs) Help Enhance Devices’ Functionalities and Battery Life to Accelerate the Adoption of Remote Monitoring

    Apollo4 Lite and Apollo4 Blue Lite: Anyone, Anytime, Anywhere

    Ambiq introduces Apollo4 Lite and Apollo4 Blue Lite

    News Highlights:

    • The new Apollo4 Lite and Blue Lite SoCs offer feature-rich capability, optimized memory, powerful graphics performance, and secureSPOT® for robust security in a lightweight solution
    • Ideal for digital health applications, such as digital stethoscopes, patient monitoring, and continuous glucose and blood pressure monitoring
    • The Apollo4 Blue Lite offers secure Bluetooth® Low Energy connectivity for communication to handheld devices, host equipment, and the Cloud

    AUSTIN, Texas, July 10, 2023 (GLOBE NEWSWIRE) — Ambiq®, a technology leader in ultra-low power semiconductor products and solutions, introduces the Apollo4 Lite and Apollo4 Blue Lite SoC to its expanding portfolio of SoCs for IoT endpoint devices, especially the remote monitoring products of the healthcare sector. This announcement follows Ambiq’s release of its Heart Kit™, an optimized open-source AI model utilizing multi-head neural networks (MH-NNs) to enable a variety of real-time heart-monitoring applications.

    The Apollo4 Lite and Blue Lite product line is the latest generation system processor solutions built upon Ambiq’s proprietary Subthreshold Power-Optimized Technology (SPOT®) platform, enabling new features while reducing devices’ overall system power consumption to extend their battery life. Both SoCs are embedded with an ultra-low power Cortex-M4 core that can operate at up to 192 MHz with turboSPOT, an audio subsystem, GPU, and ample MRAM and SRAM. They are also conveniently pin-compatible with Ambiq’s Apollo4 Plus and Blue Plus¹, providing developers with optimum flexibility for innovation.

    “Today’s patients are more empowered to monitor and advocate for their own health, and healthcare providers require more data analytics to prescribe holistic treatment,” said David Priscak, VP of Technical Solutions at Ambiq. “With bold graphics and long battery life, state-of-the-art health tracking is now more affordable and accessible thanks to these new additions to our Apollo4 SoC family.”

    Apollo4 Lite / Blue Lite Chart

    Apollo4 Lite / Blue Lite Chart

    “The global remote patient market in terms of revenue was estimated to be worth $53.6 billion in 2022 and is poised to reach $175.2 billion by 2027, growing at a CAGR of 26.7% from 2022 to 2027,” said Ms. Anu Dhiman – Lead Healthcare Analyst – MarketsandMarkets Research Pvt. Ltd. “The predominant factors influencing the growth of the market include the benefits of remote patient monitoring to reduce the burden on medical resources, the monitoring benefits of telehealth and remote patient monitoring services, advancements in telecommunications, as increasing geriatric population, and the growing need to expand healthcare access.”

    The Apollo4 Lite and the Apollo4 Blue Lite are designed for extended battery life, advanced security, and powerful graphics in small form factors, which are critical for the continued adoption of these devices. Both are now in mass production, targeting digital health products, smartwatches, fitness bands, animal trackers, voice-activated remotes, industrial maintenance, and smart home IoT devices. For more product information, visit www.ambiq.com/apollo4-lite and www.ambiq.com/apollo4-blue-lite.

    ¹ – Apollo4 Lite is pin-compatible with Apollo4 Plus (AMAP42KP-KBR); Apollo4 Blue Lite is pin-compatible with Apollo4 Blue Plus (AMA4B2KP-KXR.)

    About Ambiq

    Ambiq’s mission is to develop the lowest-power semiconductor solutions to enable intelligent devices everywhere by developing the lowest-power semiconductor solutions to drive a more energy-efficient, sustainable, and data-driven world. Ambiq has helped leading manufacturers worldwide develop products that last weeks on a single charge (rather than days) while delivering a maximum feature set in compact industrial designs. Ambiq’s goal is to take Artificial Intelligence (AI) where it has never gone before in mobile and portable devices, using Ambiq’s advanced ultra-low power system on chip (SoC) solutions. Ambiq has shipped more than 200 million units as of March 2023. For more information, visit www.ambiq.com.

    Contact

    Charlene Wan
    VP of Branding, Marketing, and Investor Relations
    [email protected]
    +1.512.879.2850

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/620a2f10-acfe-4d54-b9c3-0983c58c06f6

    https://www.globenewswire.com/NewsRoom/AttachmentNg/fd179ebf-2f60-4195-8fca-b88c7b7a852c

    GlobeNewswire Distribution ID 8870834

  • British AI Firm, Quantexa, Commits to Over £200M in AI Research and Development Investment by 2027

    AI in Context

    How Quantexa Augments and Automates Decision Intelligence with AI

    Quantexa CEO outlines vision for investment in support of UK Government’s plan to make UK an AI Hub, which includes:

    • £125M in new global investments aimed at accelerating enterprise and government agency’s ability to use trusted AI-enabled Decision Intelligence solutions
    • £85M in dedicated UK investment will create over 170 new jobs in London AI Innovation Centre team
    • Preview of Generative AI assistant shows how world-leading institutions will unlock the full potential of data to investigate risk and identify opportunity

    LONDON and NEW YORK, July 09, 2023 (GLOBE NEWSWIRE) — Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors, announced today that it will invest an additional £125M in the global artificial intelligence (AI) industry over the next three years to help clients advance the use of AI to protect, optimise, and grow their organisations. By 2027, Quantexa’s total global investment in AI will reach more than £200M.

    The investment marks Quantexa’s continued advancements in AI with the preview of its Generative AI technology, Q Assist. Quantexa also furthered its commitment to advancing the company’s existing AI Stack to enable its growing global ecosystem of clients and partners to unlock new industry-specific use cases for financial services, insurance, telecommunications, healthcare, and in the public sector. Quantexa’s Decision Intelligence platform and suite of solutions for data management, customer intelligence, KYC, risk, fraud, and financial crime have been deployed in over 70 countries.

    Analysis from University of Washington suggests this investment will boost the global AI industry by £600M as the multiplier effect is realised.

    AI in Context: How Quantexa Augments and Automates Decision Intelligence with AI

    Quantexa Limited

    Preview of Generative AI Assistant Breaks New Ground
    Built on Quantexa’s Decision Intelligence Platform, the technology preview of Q Assist, a generative AI assistant, demonstrates the potential of using LLM’s to create an intuitive and conversational interface bringing new efficiencies for analysts working with data to identify risks as part of investigations. For organisations, the potential benefit is significant – as the AI assistant allows all analyst staff to become as effective as the most experienced investigators.

    Q Assist is LLM agnostic and will allow clients to use their own proprietary, open source, or commercially available models including ChatGPTTM, a leading LLM from OpenAI. Quantexa’s market-leading entity resolution, graph analytics, and scoring capabilities become turbo-charged when they can be queried with natural language questions and prompts in Quantexa’s Decision Intelligence Platform.

    Today, in a video showcase, Quantexa demonstrated one of what could become many potential use cases for Q Assist. The financial crime investigation scenario was chosen to show the potential in using natural language to query vast amounts of structured and unstructured data at scale, allowing even junior analysts to understand the complex data behind graph analytics and alerts. The preview also showed the ability to automate the generation of Suspicious Activity Reports (SARs) and investigative summaries – possible in close to 100 languages – driving further efficiency in what is typically a manually intensive process and allowing more time to be redirected to strategic activities.

    AI Throughout Quantexa’s Decision Intelligence Platform Delivers Business Value
    Enterprises and government agencies are using Quantexa’s Decision Intelligence to become more effective and efficient at organising siloed, messy data to obtain 360-degree views of customers and suppliers to identify fraud, qualify eligibility for services, stop dangerous goods at borders, or optimise supply chains.

    Quantexa is using three core principles to responsibly build out its AI Stack:

    • Context-Based Learning: Just as humans require full context to make informed decisions, so does AI. Without context, even the smartest machine learning or deep learning algorithms lack accuracy to be deployed reliably. For example, it’s impossible for a person or AI model to know if a single bank transaction in isolation is money laundering. Quantexa builds true context by using data to create single views of people, organisations, places, and other entities and assembles them visually to show complex interactions between entities. This context is what enables a person or AI to make an accurate decision.
    • Composite AI: Quantexa’s Composite AI Stack aggregates the outputs of many different techniques, including machine learning, natural language processing and deep learning. Combining these with input from subject matter experts, organisations can continually use analytics to improve decisioning to protect, optimise, and grow. Quantexa uses exclusive access to huge volumes of structured and unstructured industry data to train its AI and provides out-of-the-box open models, giving clients the ability to modify or create their own.
    • Explainability and Trust: In the highly regulated environments that organisations work in, it is crucial that decisions are transparent and explainable with no suggestion of bias. Quantexa’s technology and governance uses context-based techniques and composite AI to drive adoption of explainable outcomes without privacy concerns. Quantexa publicly maintains its AI ethics and safety guidelines here.

    Rishi Sunak, Prime Minister of the United Kingdom, said:
    “We want to ensure the UK remains the best place in the world to build, test, and use safe AI technology. Quantexa’s new £85M London AI Innovation Centre will help cement this reality. It will create over 170 jobs, harness the extraordinary potential of AI as we grow our economy, and lead the way on responsible AI development around the world.”

    Chloe Smith, Technology Secretary, said:
    “The Government is serious about AI, which is why we’ve invested £2.5B in AI infrastructure and skills since 2014 and this year set out our plan for AI regulation to drive innovation and build trust. Quantexa’s investment is a huge vote of confidence in those plans and will unlock new opportunities for growth and job creation, enabling us to continue to pave the way as a global leader in the development of AI.”

    Vishal Marria, CEO and Founder, Quantexa, said:
    “While many companies are talking about AI and machine learning, we have been investing in it since our inception. We are investing our time, money, and resources into the biggest technological breakthrough for generations as it will transform how organizations make decisions. We’re proud to invest in London-based innovation but the impact will be felt by the global economy and will start a ripple effect that will unlock decision intelligence capabilities for our clients and their respective industries.” 

    Dr Oren Etzioni, Professor at the University of Washington’s Computer Science and founding CEO of the Allen Institute for AI, said: “An investment of 100 AI jobs will drive economic growth not just in London but around the world. The places most likely to benefit are AI innovation hubs like New York City, Seattle, and San Francisco. Based on my research into the impact of AI on employment and economic growth, the long-term monetary benefits of this announcement will increase significantly because of the multiplier effect from job creation and innovation. An initial investment of £200M is likely to benefit the wider AI industry by £600M globally within three years.” 

    To learn more about how your organisation can benefit from Quantexa’s AI investment, innovation, and ethical practices, please visit here.

    About Quantexa
    Quantexa is a global data and analytics software company pioneering Decision Intelligence that empowers organisations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, KYC, customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

    The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 650 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, New York, Boston, Toronto, Malaga, Brussels, Amsterdam, Ireland, Luxemburg, Singapore, Melbourne, Sydney, and the UAE. For more information, please visit www.quantexa.com or follow us on LinkedIn.

    Media Enquiries
    C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight
    E: [email protected]

    C: Adam Jaffe, SVP of Corporate Marketing
    T: +1 609 502 6889
    E: [email protected]
    – or –
    [email protected]

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/afbbd220-e3ee-4c36-b53e-3f10d3634414

    GlobeNewswire Distribution ID 1000829195

  • Floship CEO Josh Tsui to Deliver Executive Vision Talk on Future of Logistics Technology & Accept Award at New York’s Lead Innovation Summit

    Tsui to touch on the company’s future ambitions & strategic road map including supply chain circularity and the portal’s AI capabilities

    Floship CEO Joshua Tsui

    Floship CEO, Josh Tsui

    NEW YORK and HONG KONG, July 05, 2023 (GLOBE NEWSWIRE) — Floship, a leading global circular supply chain solutions provider, today announced its participation in The Lead Innovation Summit, a leading strategy conference for global decision-makers and executives in today’s retail and consumer industries. The conference takes place in New York City between 12 & 13 July.

    Floship CEO Josh Tsui will deliver his Vision Talk on Wednesday, 12 July during the session “Optimizing Digital Commerce Opportunity” fielding questions from Dawit Heck of Bain Capital Ventures. Tsui will share information about Floship, his strategic vision, as well as the company’s transformational ambitions including his thoughts on the future of generative AI in e-commerce to an audience of 2000+ executives from major global brand retailers.

    As part of his talk, Tsui will share information about Floship’s holistic circular supply chain ecosystem, illustrating how it connects every core component across the value chain from the manufacturer, warehouse systems, delivery mechanisms, and returns solutions through a wholly integrated platform.

    Also at The Summit, Floship will be among the companies recognized on The Lead’s Leading 100 List in an award ceremony, which honors innovative tech start-ups that are driving the future of brand-to-consumer businesses, especially in helping these businesses adopt circular supply chains.

    Floship Leaders- Headshots_Josh

    “It is an extremely exciting time here at Floship, and I’m honored that we’re being acknowledged for our disruptive innovations toward the business-to-consumer model. Supply chain circularity and generative AI are extremely important supply chain focus areas for merchants as they work hand-in-hand to minimize the use of raw materials, reduce excessive amounts of discarded waste materials, and automate many manually intensive processes,” said Tsui. “We believe the Lead Innovation Summit provides the necessary backdrop to continue to tell this story to an audience who are cognizant of the need to build more sustainable and intelligent supply chains by leveraging technologies that empower consumers, businesses, and the economy to be more efficient with a leaner amount of resources.”

    Circular supply chains involve a company reusing or repurposing waste and customer returns to convert those resources into new or refurbished products, and this strategy is critical in building global partnerships. Floship recently announced one such partnership with FedEx that is designed to provide enhanced fulfillment and logistics services to e-tailers worldwide. The partnership gives FedEx’s e-commerce customers access to Floship’s global network of warehouses and powerful logistics platform’s capabilities to streamline their e-commerce fulfillment operations. At the same time, Floship’s customers will be able to leverage FedEx global networks as well as a full range of FedEx extensive transportation options to optimize their operations.

    The Lead Innovation Summit is where 2,000+ leaders from the fashion, beauty, home, consumer & retail innovation communities converge to learn from and connect with scaled brands, digital natives, & technology enablers. The two-day summit features more than 140 stand-out speakers and 45 content sessions and breaks down every aspect of a brand’s direct-to-consumer business, online and offline.

    About Floship
    Floship’s global circular supply chain ecosystem solutions cover all aspects of the global supply chain, ensuring minimal operation effort for e-commerce businesses while exceeding their expectations, allowing business owners to concentrate on driving growth and investment flexibility while gaining peace of mind. Learn more at www.floship.com or follow us on LinkedIn.

    E [email protected]   W www.floship.com
    Level 7, 18 Salisbury Rd, Tsim Sha Tsui, Hong Kong
    香港尖沙咀梳士巴利道18號7樓

    For more information about Floship, please contact:

    James Linacre, PR & Communications Lead

    Phone: (+852) 5333 9420

    Email: [email protected]

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6e85ddb6-bd4c-4a24-9422-a4429f79a882

    GlobeNewswire Distribution ID 8868173

  • Aztiq and Innobic Announce Pricing of Secondary Sale of Lotus Common Stock by AEMH

    LONDON and BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) — Aztiq Pharma Partners (“Aztiq”), a private equity company focused on the life sciences sector, and Innobic (Asia) Company Limited (“Innobic”), the life science arm of Thai oil and gas conglomerate PTT Public Company Limited (“PTT”) (collectively, “the shareholders”), today announced the pricing of a sale of 25,095,850 shares of Lotus Pharmaceuticals (1795:TT; “Lotus,” “the company”), a multinational pharmaceutical company, at a price of NT$297 per share. The trade will be settled on July 5, 2023, subject to satisfaction of customary settlement procedures. The sale is being executed by Alvogen Emerging Market Holdings Limited (“AEMH”), which will continue to own 41% of Lotus common stock after the close of the transaction. Inclusive of Innobic’s direct holdings of Lotus, the shareholders will continue to own approximately 47.7% of the company.

    Robert Wessman, Founder of Aztiq, commented: “Today’s announcement is a big step in the evolution of Lotus that started as a company whose business was nearly entirely domestic. The company today has evolved into a global pharmaceutical company with a vast portfolio of products and a global reach that touches nearly every corner of the world through the company’s export business or through Lotus’s own commercial infrastructure that spreads throughout Asia. As Chairman, I look forward to continuing to work with Lotus’ proven management team that has led this transformation to collaborate on strategy and grow the business going forward.”

    Dr. Buranin Rattanasombat, Chief New Business and Infrastructure Officer of PTT, and Chairman of Innobic, commented: “This transaction is a significant step for Lotus as it concurrently increases free-float of the stock and diversifies the shareholder base with strong institutional investors. As a leading shareholder of Lotus, our interests remain truly aligned with those of the company and its valued shareholders.”

    J.P. Morgan and Credit Suisse are acting as placing agents for the trade.

    About Aztiq

    Aztiq is a visionary healthcare focused private equity company dedicated to fostering innovation and driving positive change within the industry. Led by Robert Wessman and a team of veteran entrepreneurs, Aztiq is committed to identifying, investing in, and nurturing ground-breaking healthcare solutions in pharma and biotech to address global healthcare challenges. By leveraging the cumulative experience of the team, Aztiq aims to improve patient outcomes, increase access to quality healthcare, and create a more efficient and sustainable healthcare ecosystem. With a proven track record of success, Aztiq continues to make a lasting impact on the health and well-being of people around the world. For more information, please visit www.aztiq.com and follow Aztiq on LinkedIn.

    About Innobic

    Innobic (Asia) Company Limited is a wholly-owned subsidiary of PTT, the largest energy company in Thailand majority owned by Ministry of Finance Thailand and listed in Fortune Global 500. PTT has moved from a national energy provider to a multinational conglomerate and started to diversify the business into new sectors, including Life Science, Renewables, Electricity value chain, and Ventures, to serve as its new S-curve. It officially established Innobic in December 2020 for a strategic goal to building up a new footprint in Life Science fields for PTT Group, with an initial focus on pharmaceuticals, and aims to make Innobic become a leading Life Science company in the region to bring best science and enhance life qualify of people. For more information, please visit www.innobicasia.com

    Media Enquiries:
    
    Ming Li
    +16465093032
    [email protected]
    
    Jaruchai Sutjarittam
    +66888924564
    [email protected]

    GlobeNewswire Distribution ID 1000828093